Human adipose tissue expansion in pregnancy is impaired in gestational diabetes mellitus

Diabetologia

Volumn 58, Issue 9, 2015, Pages 2106-2114

  Rojas Rodriguez, Raziel ^a   Lifshitz, Lawrence M ^a   Bellve, Karl D ^a   Min, So Yun ^a   Pires, Jacqueline ^a   Leung, Katherine ^a   Boeras, Crina ^a   Sert, Aylin ^a   Draper, Jacqueline T ^a   Corvera, Silvia ^a   Moore Simas, Tiffany A ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Adiposity; Endothelial cell; FIJI; IGF 1; IGF 2; Insulin resistance; Vascularisation; Visceral fat

Indexed keywords

COLLAGEN; SOMATOMEDIN BINDING PROTEIN 5; GLUCOSE BLOOD LEVEL; SOMATOMEDIN B; SOMATOMEDIN C;

ADIPOCYTE; ADIPOSE TISSUE; ADULT; ANGIOGENESIS; ARTICLE; CAPILLARY DENSITY; CELL SIZE; CESAREAN SECTION; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETOGENESIS; DISEASE PREDISPOSITION; FEMALE; GENE EXPRESSION; GLUCOSE TOLERANCE; HUMAN; HUMAN TISSUE; HYPERTROPHY; INTRAABDOMINAL FAT; NON INSULIN DEPENDENT DIABETES MELLITUS; OMENTUM; PREGNANCY; PREGNANCY DIABETES MELLITUS; PREGNANT WOMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SUBCUTANEOUS FAT; ADIPOGENESIS; ANALYSIS; CAPILLARY; CYTOLOGY; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; METABOLISM; OBESITY; PATHOPHYSIOLOGY;

ADIPOCYTES; ADIPOGENESIS; ADIPOSE TISSUE; ADIPOSITY; ADULT; BLOOD GLUCOSE; CAPILLARIES; CROSS-SECTIONAL STUDIES; DIABETES, GESTATIONAL; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 5; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; NEOVASCULARIZATION, PHYSIOLOGIC; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PREGNANCY; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84938751892     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-015-3662-0     Document Type: Article

References (50)

1. Sacks DA, Hadden DR, Maresh M et al (2012) Frequency of gestational diabetes mellitus at collaborating centers based on IADPSG consensus panel-recommended criteria: the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study. Diabetes Care 35:526–528
2. Getahun D, Nath C, Ananth CV, Chavez MR, Smulian JC (2008) Gestational diabetes in the United States: temporal trends 1989 through 2004. Am J Obstet Gynecol 198(525):e521–e525
3. Albrecht SS, Kuklina EV, Bansil P et al (2010) Diabetes trends among delivery hospitalizations in the U.S., 1994–2004. Diabetes Care 33:768–773
4. Moore Simas TA, Doyle Curiale DK, Hardy J, Jackson S, Zhang Y, Liao X (2010) Efforts needed to provide Institute of Medicine-recommended guidelines for gestational weight gain. Obstet Gynecol 115:777–783
5. Metzger BE (2007) Long-term outcomes in mothers diagnosed with gestational diabetes mellitus and their offspring. Clin Obstet Gynecol 50:972–979
6. Hillier TA, Pedula KL, Schmidt MM, Mullen JA, Charles MA, Pettitt DJ (2007) Childhood obesity and metabolic imprinting: the ongoing effects of maternal hyperglycemia. Diabetes Care 30:2287–2292
7. Malcolm J (2012) Through the looking glass: gestational diabetes as a predictor of maternal and offspring long-term health. Diabetes Metab Res Rev 28:307–311
8. Kjos SL, Peters RK, Xiang A, Henry OA, Montoro M, Buchanan TA (1995) Predicting future diabetes in Latino women with gestational diabetes. Utility of early postpartum glucose tolerance testing. Diabetes 44:586–591
9. Cheung NW, Byth K (2003) Population health significance of gestational diabetes. Diabetes Care 26:2005–2009
10. Gray SL, Vidal-Puig AJ (2007) Adipose tissue expandability in the maintenance of metabolic homeostasis. Nutr Rev 65:S7–S12
11. Virtue S, Vidal-Puig A (2010) Adipose tissue expandability, lipotoxicity and the metabolic syndrome – an allostatic perspective. Biochim Biophys Acta 1801:338–349
12. Gupta D, Krueger CB, Lastra G (2012) Over-nutrition, obesity and insulin resistance in the development of beta-cell dysfunction. Curr Diabetes Rev 8:76–83
13. Summers SA (2006) Ceramides in insulin resistance and lipotoxicity. Prog Lipid Res 45:42–72
14. Kim JY, van de Wall E, Laplante M et al (2007) Obesity-associated improvements in metabolic profile through expansion of adipose tissue. J Clin Invest 117:2621–2637
15. McLaughlin T, Lamendola C, Liu A, Abbasi F (2011) Preferential fat deposition in subcutaneous versus visceral depots is associated with insulin sensitivity. J Clin Endocrinol Metab 96:E1756–E1760
16. Tchernof A, Despres JP (2013) Pathophysiology of human visceral obesity: an update. Physiol Rev 93:359–404
17. Alligier M, Gabert L, Meugnier E et al (2013) Visceral fat accumulation during lipid overfeeding is related to subcutaneous adipose tissue characteristics in healthy men. J Clin Endocrinol Metab 98:802–810
18. Herrera E (2000) Metabolic adaptations in pregnancy and their implications for the availability of substrates to the fetus. Eur J Clin Nutr 54(Suppl 1):S47–S51
19. Ryan EA, O’Sullivan MJ, Skyler JS (1985) Insulin action during pregnancy. Studies with the euglycemic clamp technique. Diabetes 34:380–389
20. Catalano PM (2014) Trying to understand gestational diabetes. Diabet Med 31:273–281
21. Kirwan JP, Hauguel-De Mouzon S, Lepercq J et al (2002) TNF-alpha is a predictor of insulin resistance in human pregnancy. Diabetes 51:2207–2213
22. Laursen LS, Overgaard MT, Soe R et al (2001) Pregnancy-associated plasma protein-A (PAPP-A) cleaves insulin-like growth factor binding protein (IGFBP)-5 independent of IGF: implications for the mechanism of IGFBP-4 proteolysis by PAPP-A. FEBS Lett 504:36–40
23. Beattie J, Allan GJ, Lochrie JD, Flint DJ (2006) Insulin-like growth factor-binding protein-5 (IGFBP-5): a critical member of the IGF axis. Biochem J 395:1–19
24. Garten A, Schuster S, Kiess W (2012) The insulin-like growth factors in adipogenesis and obesity. Endocrinol Metab Clin N Am 41:283–295, v-vi
25. Huang L, Liu J, Feng L, Chen Y, Zhang J, Wang W (2014) Maternal prepregnancy obesity is associated with higher risk of placental pathological lesions. Placenta 35:563–569
26. Jones CJ, Fox H (1976) Placental changes in gestational diabetes. An ultrastructural study. Obstet Gynecol 48:274–280
27. Mele J, Muralimanoharan S, Maloyan A, Myatt L (2014) Impaired mitochondrial function in human placenta with increased maternal adiposity. Am J Physiol Endocrinol Metab 307:E419–E425
28. O’Tierney-Ginn P, Presley L, Myers S, Catalano P (2015) Placental growth response to maternal insulin in early pregnancy. J Clin Endocrinol Metab 100:159–165
29. Landy HJ, Gomez-Marin O, O’Sullivan MJ (1996) Diagnosing gestational diabetes mellitus: use of a glucose screen without administering the glucose tolerance test. Obstet Gynecol 87:395–400
30. Atilano LC, Lee-Parritz A, Lieberman E, Cohen AP, Barbieri RL (1999) Alternative methods of diagnosing gestational diabetes mellitus. Am J Obstet Gynecol 181:1158–1161
31. Gealekman O, Guseva N, Hartigan C et al (2011) Depot-specific differences and insufficient subcutaneous adipose tissue angiogenesis in human obesity. Circulation 123:186–194
32. Schindelin J, Arganda-Carreras I, Frise E et al (2012) Fiji: an open-source platform for biological-image analysis. Nat Methods 9:676–682
33. Rojas-Rodriguez R, Gealekman O, Kruse ME et al (2014) Adipose tissue angiogenesis assay. Methods Enzymol 537:75–91
34. Hoffstedt J, Arner E, Wahrenberg H et al (2010) Regional impact of adipose tissue morphology on the metabolic profile in morbid obesity. Diabetologia 53:2496–2503
35. Veilleux A, Caron-Jobin M, Noel S, Laberge PY, Tchernof A (2011) Visceral adipocyte hypertrophy is associated with dyslipidemia independent of body composition and fat distribution in women. Diabetes 60:1504–1511
36. Bouloumie A, Lolmede K, Sengenes C, Galitzky J, Lafontan M (2002) Angiogenesis in adipose tissue. Ann Endocrinol (Paris) 63:91–95
37. Hausman GJ, Richardson RL (2004) Adipose tissue angiogenesis. J Anim Sci 82:925–934
38. Tran KV, Gealekman O, Frontini A et al (2012) The vascular endothelium of the adipose tissue gives rise to both white and brown fat cells. Cell Metab 15:222–229
39. Divoux A, Tordjman J, Lacasa D et al (2010) Fibrosis in human adipose tissue: composition, distribution, and link with lipid metabolism and fat mass loss. Diabetes 59:2817–2825
40. Henegar C, Tordjman J, Achard V et al (2008) Adipose tissue transcriptomic signature highlights the pathological relevance of extracellular matrix in human obesity. Genome Biol 9:R14
41. Keller P, Gburcik V, Petrovic N et al (2011) Gene-chip studies of adipogenesis-regulated microRNAs in mouse primary adipocytes and human obesity. BMC Endocr Disord 11:7
42. Tchoukalova YD, Votruba SB, Tchkonia T, Giorgadze N, Kirkland JL, Jensen MD (2010) Regional differences in cellular mechanisms of adipose tissue gain with overfeeding. Proc Natl Acad Sci U S A 107:18226–18231
43. Kim JI, Huh JY, Sohn JH et al (2015) Lipid-overloaded enlarged adipocytes provoke insulin resistance independent of inflammation. Mol Cell Biol 35:1686–1699
44. Lu Q, Li M, Zou Y, Cao T (2014) Induction of adipocyte hyperplasia in subcutaneous fat depot alleviated type 2 diabetes symptoms in obese mice. Obesity (Silver Spring) 22:1623–1631
45. Han J, Lee JE, Jin J et al (2011) The spatiotemporal development of adipose tissue. Development 138:5027–5037
46. Tang W, Zeve D, Suh JM et al (2008) White fat progenitor cells reside in the adipose vasculature. Science 322:583–586
47. Spencer M, Unal R, Zhu B et al (2011) Adipose tissue extracellular matrix and vascular abnormalities in obesity and insulin resistance. J Clin Endocrinol Metab 96:E1990–E1998
48. Xin X, Rodrigues M, Umapathi M et al (2013) Hypoxic retinal Muller cells promote vascular permeability by HIF-1-dependent up-regulation of angiopoietin-like 4. Proc Natl Acad Sci U S A 110:E3425–E3434
49. Gealekman O, Gurav K, Chouinard M et al (2014) Control of adipose tissue expandability in response to high fat diet by the insulin-like growth factor-binding protein-4. J Biol Chem 289:18327–18338
50. Yamada PM, Mehta HH, Hwang D, Roos KP, Hevener AL, Lee KW (2010) Evidence of a role for insulin-like growth factor binding protein (IGFBP)-3 in metabolic regulation. Endocrinology 151:5741–5750